Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurotropin in low back pain patients with sarcopenia (NTN-Sa-1)
jRCTs031220709Active, not recruiting
- Sponsor
- Nippon Zoki Pharmaceutical
- Start
- Jun 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial in Sarcopenia and lumbodynia (LBP) comparing Neurotropin with Placebo (2 arms). Primary endpoint: Change in 4-meter walking speed at 12 weeks. Started Jun 2023; status: active, not recruiting.
02
Drugs
vaccinia virus-inoculated rabbit skin extract
03
Conditions
Sarcopenialumbodynia (LBP)
Beyond the preview
Go deeper on jRCTs031220709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220709.